Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.41 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorobenzene SCHEMBL1881543 | 0.86 | PGR (0.54) | CA12CA9TSHRMCOLN3HTT | |
| SCHEMBL25137428 | 0.80 | CA12 (0.55) | CA12CA9TSHRMCOLN3NR1H3 | |
| Lithium SCHEMBL31041149 | 0.78 | CA12 (0.53) | CA12CA9TSHRMCOLN3NR1H3 | |
| SCHEMBL171307 | 0.78 | ALDH1A1 (0.54) | CA12CA9TSHRMCOLN3HTT | |
| Sulfuric Acid SCHEMBL4958447 | 0.78 | HPGD (0.54) | CA12CA9TSHRHTTMEN1 | |
| SCHEMBL11551098 | 0.78 | CA12 (0.53) | CA12CA9TSHRMCOLN3NR1H3 | |
| SCHEMBL7738180 | 0.77 | TDP1 (0.50) | CA12CA9TSHRMCOLN3KDM4E | |
| SCHEMBL5656924 | 0.77 | CHRM5 (0.50) | MCOLN3HTTMEN1KMT2AKDM4E | |
| SCHEMBL27941188 | 0.77 | MAPT (0.35) | CA12CA9TSHRMCOLN3NR1I2 | |
| SCHEMBL2136688 | 0.77 | ALDH1A1 (0.52) | CA12CA9MCOLN3HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | claimed |
| US-7223301-B2 | Anthrapyridone compound, water-based magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-05-29 | — | — | US | claimed |
| US-20060219131-A1 | Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-10-05 | — | — | US | claimed |
| EP-1626069-A1 | ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-02-15 | — | — | EP | claimed |
| EP-1204669-B1 | TRICYCLIC MONOSACCHARIDE DERIVATIVES USEFUL IN TREATING ACUTE ISCHEMIA-INDUCED NEURODEGENERATION | ORTHO MCNEIL PHARM INC (US) | 2005-11-09 | — | — | EP | claimed |
| EP-1158973-B1 | USE OF SULFAMATE DERIVATIVES FOR TREATING IMPULSE CONTROL DISORDERS | UNIV CINCINNATI (US) | 2005-05-04 | — | — | EP | claimed |
| WO-2003029226-A1 | HETEROCYCLYL SUBSTITUTED PHENOXYALKYL-, PHENYLTHIOALKYL-, PHENYLAMINOALKYL- AND PHENYLALKYL-SULFAMOYLCARBOXAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | WO | claimed |
| US-4140684-A | FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1979-02-20 | — | — | US | claimed |
| US-4017477-A | 3-Halogeno-6-hydroxy-pyridone-(2) azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-04-12 | — | — | US | claimed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | claimed |
| US-11916195-B2 | Electrolyte solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20230387465-A1 | COMPOUND, COMPOSITION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11666584-B2 | Steroidal hormones for the treatment and prevention of wave burst arrhythmia | Assistance Publique—Hopitaux de Paris (FR) | 2023-06-06 | — | — | US | disclosed |
| US-20230145113-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, MODULE AND COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230129817-A1 | ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-4179435-A | SULPHONIC ACID-FREE | CIBA-GEIGY CORPORATION (US) | 1979-12-18 | — | — | US | disclosed |
| US-4140684-A | FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1979-02-20 | — | — | US | disclosed |
| US-4115381-A | FOR POLYESTER FIBERS | CIBA-GEIGY CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | disclosed |
| US-3979378-A | Water-soluble azo dyes having a substituted 2-hydroxypyridone (6) coupling component | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | ABL1, ATXN2L, ANXA7 | CA12 2829/4885CA9 1355/4885TSHR 3980/4885 |
| US-11666584-B2 | Steroidal hormones for the treatment and prevention of wave burst arrhythmia | SHBG, NR5A1, HSD17B11 | CA12 3722/4885CA9 4612/4885TSHR 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.